Skip to Main Content

HelixTalk

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

HelixTalk is available via Apple Podcasts (or by searching for HelixTalk), by subscribing to our RSS feed, subscribing to our mailing list, or by listening to any episode in your browser (below).

Subscribe to Our Mailing List

HelixTalk Episodes

HelixTalk #178 - Law & Order: Pharmacy Edition. A Concise Review of High-Yield Pharmacy Law Topics for the MPJE

Date posted: February 13, 2024, 6:00 am

In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Rosalind Franklin and a co-course director for the Pharmacy Law course at the university. We review some of the key points regarding federal and Illinois pharmacy law – a must-listen especially for graduates preparing for their MPJE exam after graduation!


HelixTalk #177 - The Antidote Arsenal: Exploring the Emergency Toolbox for Anticoagulant Reversals

Date posted: January 23, 2024, 6:00 am

In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaban, edoxaban, and rivaroxaban).


HelixTalk #176 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 2)

Date posted: January 2, 2024, 6:00 am

In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).


HelixTalk #175 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 1)

Date posted: December 13, 2023, 11:00 am

In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).